Pseudomyxoma peritonei other imaging findings

Jump to navigation Jump to search

Pseudomyxoma peritonei Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Pseudomyxoma peritonei from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pseudomyxoma peritonei other imaging findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pseudomyxoma peritonei other imaging findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pseudomyxoma peritonei other imaging findings

CDC on Pseudomyxoma peritonei other imaging findings

Pseudomyxoma peritonei other imaging findings in the news

Blogs on Pseudomyxoma peritonei other imaging findings

Directions to Hospitals Treating Pseudomyxoma peritonei

Risk calculators and risk factors for Pseudomyxoma peritonei other imaging findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]

Overview

Pseudomyxoma peritonei is rare clinical entity characterized by the presence of abundant mucus in intraperitoneal cavities, mesentery, omentum. The tumor arises mostly from primary appendiceal mucinous neoplasm. CT of abdomen and MRI are most useful imaging studies, but other imaging tools such as PET scan can be used.

Other Imaging Findings

Other imaging studies such as PET-scan may be used, preoperative 18F-FDG PET may be helpful to detect tumors grade and whether cytoreduction surgery is completed or not.[1]

References

  1. Passot G, Glehen O, Pellet O, Isaac S, Tychyj C, Mohamed F, Giammarile F, Gilly FN, Cotte E (March 2010). "Pseudomyxoma peritonei: role of 18F-FDG PET in preoperative evaluation of pathological grade and potential for complete cytoreduction". Eur J Surg Oncol. 36 (3): 315–23. doi:10.1016/j.ejso.2009.09.001. PMID 19818580.


Template:WikiDoc Sources